College of Tokyo, Astellas Enter Second Part of Strategic Partnership for Co-creation of Progressive New Medicines and Medical Options

TOKYO, April 25, 2022 /PRNewswire/ — The College of Tokyo (President: Teruo Fujii, Ph.D.) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.; hereafter “Astellas”) entered the second section of their collaboration for co-creating progressive new medicines and medical options, referred to as the Astellas Alliance Acceleration Program (AAAP), right this moment….

Read More